Keytruda 100mg/4ml Injection Pembrolizumab

Keytruda 100mg Injection is an immunotherapy medication containing pembrolizumab, a monoclonal antibody. It works by blocking the PD-1/PD-L1 pathway to help your immune system detect and attack cancer cells. It is used to treat various cancers, including lung cancer, melanoma, and Hodgkin lymphoma, often in advanced or metastatic stages.

Yes, you can buy Keytruda 100mg Injection from Jasmeds, which is a reliable provider of wellness medicines in Pakistan offering 24/7 delivery service.

If you suspect an overdose of Keytruda 100mg Injection, seek immediate medical attention. Overdose is unlikely as it is administered by a healthcare professional, but in case of any adverse symptoms, such as severe immune-related reactions, contact your doctor or emergency services promptly for evaluation and management.

Yes, Keytruda 100mg Injection can potentially affect kidney function, as it may cause immune-related adverse effects, including nephritis (kidney inflammation). Kidney patients should inform their doctor before starting Keytruda, and regular monitoring of kidney function is essential during treatment to detect and manage any complications early. Always follow your oncologist’s guidance.

Keytruda 100mg is administered as an injection, not available in tablet form. After receiving a Keytruda injection, you may experience side effects like fatigue or dizziness, which could impair your ability to drive. If you feel unwell, it’s best to avoid driving and consult your doctor for guidance. 

Keytruda should be stopped if you experience severe immune-related side effects, such as pneumonitis, colitis, hepatitis, nephritis, endocrinopathies, or severe infusion reactions, as determined by your doctor. It may also be discontinued if the cancer progresses despite treatment or if your doctor decides the risks outweigh the benefits. Always follow your oncologist’s advice regarding treatment continuation or cessation.

Keytruda should be stopped if you experience severe immune-related side effects, such as pneumonitis, colitis, hepatitis, nephritis, endocrinopathies, or severe infusion reactions, as determined by your doctor. It may also be discontinued if the cancer progresses despite treatment or if your doctor decides the risks outweigh the benefits. Always follow your oncologist’s advice regarding treatment continuation or cessation.

Response Rates by PD-L1 Levels: The effectiveness of Keytruda can vary based on the level of PD-L1 expression:

Patients with high PD-L1 levels (≥50%) had better response rates compared to those with lower levels

For patients with PD-L1 levels below 1%, the response rate for significant tumor shrinkage was about 10.7%

keytruda does affects multiple organs including lungs, liver kidneys, Endocrine Glands, skin and colon.